The reduction of miR‐129‐5p unleashed its targets COL1A1 and ITGA1 expression, which promoted IDD.44 Compared to proteins, microRNA should decrease the frequency of hazard and side effects, because it does not need to be transfected into target cells. This evidence concerns the gene ITGA1 and intervertebral disk degenerative disorder.